Comparison of EBV Serological Reactivities between Two Groups of NPC Patients Surviving More Than 7 Years or Dead 2 Years after Diagnosis
In order to use the Epstein-Barr virus (EBV) serology for prognostic evolution of nasopharyngeal carcinoma (NPC), sera of two groups of NPC patients were analyzed for EBV reactivities. Patients belonging to the first group survived more than seven years after the first diagnosis of the tumor, whereas in the second group patients died within one or two years.
KeywordsSodium Butyrate RAJI Cell Early Antigen Control Negative Seron P3HR1 Cell
Unable to display preview. Download preview PDF.